Nigel Sheail is a partner at Versant Ventures based in Basel, Switzerland, with over two decades of leadership in the pharmaceutical sector. He previously held senior business development roles at Novartis, Bayer Healthcare, and Roche.
At firms with a similar stage, sector and check size.




One email when Nigel's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckNigel Sheail is a partner at Versant Ventures based in Basel, Switzerland, with over two decades of leadership in the pharmaceutical sector. He previously held senior business development roles at Novartis, Bayer Healthcare, and Roche.
Versant Ventures has not reported a check size. It invests at seed, series a, series b.
A warm intro from a founder Versant Ventures backed works best.
Head of Licensing for its Pharma division at Roche; Head of Group M&A at Roche; Head of Business Development and Licensing at Bayer Healthcare; Global Head of Mergers & Acquisitions and Business Development & Licensing at Novartis.
Last updated 2026-10-15. Is this you? Ask for a correction.